We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-2 of 2

Securing IP in stem cells

  • Bereskin & Parr LLP
  • -
  • Canada, USA
  • -
  • April 12 2013

Stem cells are at the centre of research into regenerative medicine. They have the ability to continuously produce newly differentiated cells and

Biosimilar battlegrounds - what is new in biosimilars and where?

  • Bereskin & Parr LLP
  • -
  • Canada, European Union, USA
  • -
  • February 17 2012

Biosimilars are second entry biologic drugs